). Electrophoretic mobility shift assay (EMSA) Nuclear extracts for EMSA were prepared with nuclear and cytoplasmic extraction reagents (NE-PER; Pierce). The supernatant fraction containing the cytoplasm and the nuclear extract were prepared separately
Search Results
Meng Ren, Qingbo Guan, Xia Zhong, Bendi Gong, Ying Sun, Wei Xin, Jun Guo, Hai Wang, Ling Gao, and Jiajun Zhao
Tzu-Ying Lee, Ke-Li Tsai, Wen-Sen Lee, and Chin Hsu
nuclear protein and electrophoretic mobility shift assay (EMSA) Cells were plated at a density of 6×10 5 cells/cm 3 in a 10 cm dish. The culture medium was removed when the cells reached 90% confluence and 1 ml PBS was added to cover the cells
Carlos Stocco, Jakub Kwintkiewicz, and Zailong Cai
mobility shift assay (EMSA) Nuclear protein extracts from ovaries or corpora lutea were prepared by extracting nuclei with the following buffer: 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1 mM dithiothreitol, 25% (v/v) glycerol, 0.5 mM phenylmethylsulfonyl
Xiaodong Li, Stephanie L Nott, Yanfang Huang, Russell Hilf, Robert A Bambara, Xing Qiu, Andrei Yakovlev, Stephen Welle, and Mesut Muyan
), electrophoretic mobility shift assay (EMSA), and immunocytochemistry (ICC) Transfected or infected cells in a time-dependent manner were processed for WB, EMSA, and ICC as described previously ( Muyan et al . 2001 , Yi et al . 2002 a ). For WB, proteins were
Wen-Li Zhao, Chun-Yan Liu, Wen Liu, Di Wang, Jin-Xing Wang, and Xiao-Fan Zhao
performed an electrophoretic mobility shift assay (EMSA) experiment using kJHRE (GGCCTCCACGTG) in the Krh1 promoter of Tribolium as a probe. In the RFP-expressing cells, the nuclear extracts from normal cells, or DMSO- or 20E-treated cells could not
I K Lund, J A Hansen, H S Andersen, N P H Møller, and N Billestrup
. Differences were considered significant if P <0.05. Nuclear extracts and electrophoretic mobility shift assay (EMSA) The HEK293 cells were seeded in 10 cm tissue culture dishes (Nunc) in RPMI 1640 medium supplemented with
Jacqueline Brodie and Iain J McEwan
870 Da and 70 950 Da for the AR-DBD and AR-NTD-DBD polypeptides respectively. Protein–DNA interactions – electrophoretic mobility shift assays (EMSA) Oligonucleotides (Table 1 ) were end-labelled with 33 P γ
Yumiko Kashiwabara, Shigekazu Sasaki, Akio Matsushita, Koji Nagayama, Kenji Ohba, Hiroyuki Iwaki, Hideyuki Matsunaga, Shingo Suzuki, Hiroko Misawa, Keiko Ishizuka, Yutaka Oki, and Hirotoshi Nakamura
. Electrophoretic mobility shift assay (EMSA) for the SR region was also prepared using nuclear extracts with non-transfected CV1 cells. A 25- to 50-fold molar excess of cold oligonucleotides for 2G, 4G (sense 5′-cagtatgaattttcaatggggagatgcttttcagataagaaa-3′ and
Tetsuya Tagami, Hiroyuki Yamamoto, Kenji Moriyama, Kuniko Sawai, Takeshi Usui, Akira Shimatsu, and Mitsuhide Naruse
and detected using the streptavidine alkaline phosphatase substrate. Nuclear extracts (2.5 μg) from transfected TSA-201 cells were preincubated at room temperature in a 20 μl reaction using LightShift Chemiluminescent EMSA kit (Pierce, Rockford, IL
Gérard Triqueneaux, Sandrine Thenot, Tomoko Kakizawa, Marina P Antoch, Rachid Safi, Joseph S Takahashi, Franck Delaunay, and Vincent Laudet
before being shocked. At T0, 50% horse serum was added to the cells for 2 h. The cells were then grown in DMEM without serum for 2 days and harvested at various circadian times. Electrophoretic mobility shift assays (EMSAs